View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Dashboards
  2. Patents
January 19, 2022

Internet of Things: J&J top innovator at tail end of 2021

Yet research and innovation in internet of things in the clinical trial operations sector has declined in the last year.

By Data Journalism Team

Johnson & Johnson was the top internet of things (IoT) innovator in the clinical trial operations sector in the last quarter. The company filed 63 IoT related patents in the three months ending November 2021. That said, this was down from 96 over the same period last year.

J&J was followed by Merck with 14 IoT patent applications, Gilead Sciences (14 applications), and Bayer (12 applications).

Merck has recently ramped up R&D in IoT. It saw growth of 14.3% in related patent applications in the three months ending November compared to the same period last year - the highest percentage growth out of all companies tracked with more than 10 quarterly patents in the clinical trial operations sector.

IoT innovation declines

Nevertheless, research and innovation in IoT in the clinical trial operations sector has declined in the last year.

The most recent figures show that the number of IoT patent applications in the industry stood at 95 in the three months ending November - down from 160 over the same period last year.

Figures for patent grants related to IoT followed a similar pattern to filings - shrinking from 173 in the three months ending November last year to 94 this year.

The figures are compiled by GlobalData, who track patent filings and grants from official offices around the world. Using textual analysis, as well as official patent classifications, these patents are grouped into key thematic areas, and linked to key companies across various industries.

IoT is one of the key areas tracked by GlobalData. It has been identified as being a key disruptive force facing companies in the coming years, and is one of the areas that companies investing resources in now are expected to reap rewards from.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU